Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Anti-GCC Antibody-Drug Conjugate MLN0264

Known as: MLN0264 
An antibody-drug conjugate (ADC) containing a monoclonal antibody directed against guanylyl cyclase C (GCC or GUCY2C) conjugated to… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Guanylyl cyclase C (GCC) is a cell-surface protein that is expressed by normal intestinal epithelial cells, more than 95% of… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
2018
2018
Purpose This phase 1 dose-escalation portion of the study evaluated the safety, pharmacokinetics (PK), and antitumor activity of… Expand
  • table 1
  • table 2
  • table 3
Is this relevant?
2017
2017
SummaryBackground This phase II open-label, multicenter study evaluated the efficacy, safety, and tolerability of TAK-264 in… Expand
  • figure 1
  • table 2
  • table 1
  • table 3
Is this relevant?
2017
2017
SummaryBackground The first-in-class antibody–drug conjugate TAK-264 (formerly MLN0264) consists of an antibody targeting… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
Is this relevant?
Review
2017
Review
2017
ABSTRACT Antibody‐directed cancer chemotherapy in the form of antibody–drug conjugates (ADCs) may improve the therapeutic index… Expand
  • figure 1
Is this relevant?
2016
2016
Purpose: To assess the safety, tolerability, and preliminary antitumor activity of the investigational anti–guanylyl cyclase C… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
2016
2016
TAK-264 (formerly MLN0264) is a novel ADC consisting of a human monoclonal antibody that specifically targets GCC, the potent… Expand
Is this relevant?
2014
2014
3546 Background: This first-in-human study (NCT01577758) assessed the safety and tolerability, dose limiting toxicities (DLTs… Expand
Is this relevant?
2014
2014
Acquisition and interpretation guidelines for clinical PET/CT imaging in oncology have been designed for whole-body 18F-FDG… Expand
Is this relevant?